{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:02:56Z","timestamp":1769857376421,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["17-02-1-0633"],"award-info":[{"award-number":["17-02-1-0633"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["0802"],"award-info":[{"award-number":["0802"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA023074"],"award-info":[{"award-number":["P30 CA023074"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.tranon.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T05:34:00Z","timestamp":1538544840000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3\u2032UTR element in CSF-1R mRNA"],"prefix":"10.1016","volume":"12","author":[{"given":"Ho-Hyung","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jha\u2019nae B.","family":"Stoffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demaretta","family":"Rush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuko K.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2018.09.012_bb0030","first-page":"941","article-title":"FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro","volume":"6","author":"Kacinski","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2018.09.012_bb0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.193.6.727","article-title":"Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy","volume":"193","author":"Lin","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.tranon.2018.09.012_bb0065","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1158\/0008-5472.CAN-09-1868","article-title":"Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony stimulating factor-1 receptor","volume":"69","author":"Patsialou","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2018.09.012_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10549-010-1247-7","article-title":"Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells","volume":"129","author":"Toy","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.tranon.2018.09.012_bb0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1535370214522588","article-title":"Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer metastasis assessed with in vivo dual-modality","volume":"239","author":"Jeffery","year":"2014","journal-title":"Exp Biol Med"},{"issue":"1","key":"10.1016\/j.tranon.2018.09.012_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10585-005-0718-4","article-title":"Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis","volume":"22","author":"Toy","year":"2005","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.tranon.2018.09.012_bb0050","first-page":"1851","article-title":"Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence","volume":"4","author":"Maher","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tranon.2018.09.012_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1158\/1078-0432.CCR-0699-3","article-title":"Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis","volume":"10","author":"Kluger","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tranon.2018.09.012_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/MCB.01031-10","article-title":"Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer","volume":"31","author":"Woo","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.tranon.2018.09.012_bb0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrg3681","article-title":"Insights into RNA structure and function from genome-wide studies","volume":"15","author":"Mortimer","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.tranon.2018.09.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12848","article-title":"The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translation","volume":"7","author":"Mobin","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.tranon.2018.09.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1448","article-title":"A jack of all trades: the RNA-binding protein vigilin","volume":"8","author":"Cheng","year":"2017","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.tranon.2018.09.012_bb0080","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/onc.2008.469","article-title":"Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer","volume":"28","author":"Woo","year":"2009","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.tranon.2018.09.012_bb9605","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1593\/neo.81150","article-title":"Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony stimulating factor (CSF-1)","volume":"11","author":"Toy","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.tranon.2018.09.012_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000071773","article-title":"Vigilin and enzyme expression in isolated pancreatic acini after mellitin and gamma-interferon treatment","volume":"3","author":"Hilgendorf","year":"2003","journal-title":"Pancreatology"},{"key":"10.1016\/j.tranon.2018.09.012_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-59745-033-1_8","article-title":"A tethering approach to study proteins that activate mRNA turnover in human cells","volume":"419","author":"Clement","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.tranon.2018.09.012_bb0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: a long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol"},{"key":"10.1016\/j.tranon.2018.09.012_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cell.2015.02.043","article-title":"The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo","volume":"161","author":"Karreth","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2018.09.012_bb9610","series-title":"Oncogene and Cancer from Bench to Clinic","article-title":"Post-transcriptional regulation of proto-oncogene c-fms in breast cancer","author":"Woo","year":"2013"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523318302109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523318302109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:33:34Z","timestamp":1761834814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523318302109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1936523318302109"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2018.09.012","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3\u2032UTR element in CSF-1R mRNA","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}